SAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Tuesday reported third-quarter net income of $209.5 million.
The San Diego-based company said it had profit of $2.04 per share.
The results topped Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.58 per share.
The biopharmaceutical company posted revenue of $794.9 million in the period, which also beat Street forecasts. Eleven analysts surveyed by Zacks expected $744.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
